Interestingly, THAP10 mRNA levels in bone marrow mononuclear cells of AML1‐ETO+ AML patients who achieved complete remission after induction chemotherapy were relatively higher than the same patients at relapse (Fig 2C). The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.